Makers of mifepristone challenge ruling restricting access to drug

A maker of the abortion pill mifepristone asked the Supreme Court to block a court ruling that cut off mail-order access to the drug. The ruling was the result of a legal challenge from the state of Louisiana, which had sued the Food and Drug Administration over a 2023 policy change that removed the requirement for patients to see a health care provider in person to get mifepristone.